Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU that can be delivered via an autoinjector device at home.

Offshore fabrication firm Heerema provided valuable employment for hundreds of people across the decades until its Hartlepool ...

Here’s how it works. Space can be a wondrous place, and we've got the pictures to prove it! Take a look at our favorite space pictures here, and if you're wondering what happened to today in ...

Fighting in and around the city has escalated despite calls from the UN Security Council for the rebels to withdraw.

Nick Kirmse joined the CTVNews.ca team in 2017, working as a graphic designer and news writer before joining the digital content editing team in 2019. He specializes in livestream content ...